title: Defining the standard of care for high-grade glioma--a NICE deal for UK patients?
authors.forename: S
authors.initials: S
authors.lastname: Khanduri
authors.forename: G
authors.initials: G
authors.lastname: Gerrard
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003695:Delivery of Health Care / Q000592:standards*; D005910:Glioma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D000077204:Temozolomide; D006113:United Kingdom
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide